These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15158137)

  • 21. Multiple, PKA-dependent and PKA-independent, signals are involved in cAMP-induced PRL expression in the eosinophilic cell line Eol-1.
    Gerlo S; Verdood P; Hooghe-Peters EL; Kooijman R
    Cell Signal; 2005 Jul; 17(7):901-9. PubMed ID: 15763432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel diol-derivative of chalcone produced by bioconversion, 3-(2,3-dihydroxyphenyl)-1-phenylpropan-1-one, activates PKA/MEK/ERK signaling and antagonizes Abeta-inhibition of the cascade in cultured rat CNS neurons.
    Al Rahim M; Nakajima A; Misawa N; Shindo K; Adachi K; Shizuri Y; Ohizumi Y; Yamakuni T
    Eur J Pharmacol; 2008 Dec; 600(1-3):10-7. PubMed ID: 18948095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C- and reactive oxygen species-dependent stimulation of intracellular cAMP in human eosinophils. The role of extracellular signal-regulated protein kinases.
    Ezeamuzie CI; Taslim N
    Med Princ Pract; 2008; 17(6):468-74. PubMed ID: 18836276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline.
    Brennesvik EO; Ktori C; Ruzzin J; Jebens E; Shepherd PR; Jensen J
    Cell Signal; 2005 Dec; 17(12):1551-9. PubMed ID: 15908181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative role of upstream regulators of Akt, ERK and CREB in NCAM- and FGF2-mediated signalling.
    Ditlevsen DK; Owczarek S; Berezin V; Bock E
    Neurochem Int; 2008 Nov; 53(5):137-47. PubMed ID: 18656513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More PKA independent beta-adrenergic signalling via cAMP: is Rap1-mediated glucose uptake in vascular smooth cells physiologically important?
    Jensen J
    Br J Pharmacol; 2007 Jun; 151(4):423-5. PubMed ID: 17450171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of disruption of A kinase anchoring protein-protein kinase A association on protein kinase A signalling in neuroendocrine melanotroph cells of Xenopus laevis.
    Corstens GJ; van Boxtel R; van den Hurk MJ; Roubos EW; Jenks BG
    J Neuroendocrinol; 2006 Jul; 18(7):477-83. PubMed ID: 16774496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium.
    Böhm M; Reiger B; Schwinger RH; Erdmann E
    Cardiovasc Res; 1994 Nov; 28(11):1713-9. PubMed ID: 7842467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenylyl cyclase: a new target for heart failure therapeutics.
    Feldman AM
    Circulation; 2002 Apr; 105(16):1876-8. PubMed ID: 11997269
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.
    Sussman MA; Welch S; Gude N; Khoury PR; Daniels SR; Kirkpatrick D; Walsh RA; Price RL; Lim HW; Molkentin JD
    Am J Pathol; 1999 Dec; 155(6):2101-13. PubMed ID: 10595939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.
    Miyamoto SD; Stauffer BL; Nakano S; Sobus R; Nunley K; Nelson P; Sucharov CC
    Eur Heart J; 2014 Jan; 35(1):33-41. PubMed ID: 22843448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional defects in troponin and the systems biology of heart failure.
    Solaro RJ; Burkart EM
    J Mol Cell Cardiol; 2002 Jul; 34(7):689-93. PubMed ID: 12099706
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dilated cardiomyopathy. Is its etiology still unknown?].
    e Mattos BP; Zago AJ
    Arq Bras Cardiol; 1995 Dec; 65(6):511-6. PubMed ID: 8731306
    [No Abstract]   [Full Text] [Related]  

  • 35. Dilated cardiomyopathy: learning to live with yourself.
    MacLellan WR; Lusis AJ
    Nat Med; 2003 Dec; 9(12):1455-6. PubMed ID: 14647516
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transgenic models of dilated cardiomyopathy].
    Bai YN; Hu K; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):755-8. PubMed ID: 19100123
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dilated cardiomyopathy: present views of its etiology and pathogenesis].
    Gurevich MA; Grigor'eva NM
    Klin Med (Mosk); 2001; 79(5):4-7. PubMed ID: 11510185
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertrophy and dilation: a TOTally new story?
    Baudet S
    Cardiovasc Res; 2000 Apr; 46(1):17-9. PubMed ID: 10727648
    [No Abstract]   [Full Text] [Related]  

  • 39. [Editorial comment: does intermittent dobutamine treatment produce relief in dilated cardiomyopathy?].
    Aydinlar A
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):224-5. PubMed ID: 12795251
    [No Abstract]   [Full Text] [Related]  

  • 40. AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.
    Qasim H; Rajaei M; Xu Y; Reyes-Alcaraz A; Abdelnasser HY; Stewart MD; Lahiri SK; Wehrens XHT; McConnell BK
    Circ Res; 2024 Apr; 134(8):1006-1022. PubMed ID: 38506047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.